Li S, Zhou L, Huang Y, Tang S
Bioact Mater. 2025; 48:149-170.
PMID: 40046015
PMC: 11880721.
DOI: 10.1016/j.bioactmat.2025.02.018.
Jin C, Wu P, Wu W, Chen W, Liu W, Zhu Y
Cell Biol Toxicol. 2025; 41(1):50.
PMID: 39992453
PMC: 11850457.
DOI: 10.1007/s10565-025-09998-2.
Spinelli S, Tripodi D, Corti N, Zocchi E, Bruschi M, Leoni V
Int J Mol Sci. 2025; 26(3).
PMID: 39941112
PMC: 11818369.
DOI: 10.3390/ijms26031345.
Jiang Y, Wei Z, Song Z, Yu M, Huang J, Qian H
Drug Deliv Transl Res. 2025; .
PMID: 39873880
DOI: 10.1007/s13346-025-01792-1.
Zheng L, Chang R, Liang B, Wang Y, Zhu Y, Jia Z
Cancer Drug Resist. 2025; 7():50.
PMID: 39802949
PMC: 11724354.
DOI: 10.20517/cdr.2024.107.
Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy.
Liu H, Geng Z, Su J
Extracell Vesicles Circ Nucl Acids. 2024; 3(2):63-86.
PMID: 39698442
PMC: 11648430.
DOI: 10.20517/evcna.2022.04.
Nucleic acid functionalized extracellular vesicles as promising therapeutic systems for nanomedicine.
Liu C, He D, Cen H, Chen H, Li L, Nie G
Extracell Vesicles Circ Nucl Acids. 2024; 3(1):14-30.
PMID: 39697871
PMC: 11648500.
DOI: 10.20517/evcna.2021.21.
Highly Efficient Delivery of Novel MiR-13896 by Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Inhibits Gastric Cancer Progression by Targeting ATG2A-Mediated Autophagy.
Wu P, Wang M, Jin C, Li L, Tang Y, Wang Z
Biomater Res. 2024; 28:0119.
PMID: 39697182
PMC: 11654722.
DOI: 10.34133/bmr.0119.
Sparstolonin B potentiates the antitumor activity of nanovesicle-loaded drugs by suppressing the phagocytosis of macrophages in vivo.
Zhang Y, Mou Z, Song W, He X, Yi Q, Wang Z
J Nanobiotechnology. 2024; 22(1):759.
PMID: 39696573
PMC: 11657701.
DOI: 10.1186/s12951-024-03001-6.
Emerging advanced approaches for liquid biopsy: nucleic acid assays of extracellular vesicles.
Wang D, Shen Y, Qian H, Jiang J, Xu W
Theranostics. 2024; 14(19):7309-7332.
PMID: 39659566
PMC: 11626945.
DOI: 10.7150/thno.102437.
Therapeutically Harnessing Tumor Cell-Derived Extracellular Vesicles for Multiple Myeloma: Recent Advances and Future Perspectives.
Xiao S, Chen L, Chen Z, Li Q
Pharmaceutics. 2024; 16(11).
PMID: 39598562
PMC: 11597712.
DOI: 10.3390/pharmaceutics16111439.
Research hotspots and trends of mesenchymal stem cell-derived extracellular vesicles for drug delivery: a bibliometric and visualization analysis from 2013 to 2023.
Zhao T, Mu Y, Deng H, Liang K, Zhou F, Lin Q
Front Cell Dev Biol. 2024; 12:1412363.
PMID: 39539963
PMC: 11557358.
DOI: 10.3389/fcell.2024.1412363.
Ribosomal proteins in hepatocellular carcinoma: mysterious but promising.
Su Q, Sun H, Mei L, Yan Y, Ji H, Chang L
Cell Biosci. 2024; 14(1):133.
PMID: 39487553
PMC: 11529329.
DOI: 10.1186/s13578-024-01316-3.
Basic Guide for Approaching Drug Delivery with Extracellular Vesicles.
Brezgin S, Danilik O, Yudaeva A, Kachanov A, Kostyusheva A, Karandashov I
Int J Mol Sci. 2024; 25(19).
PMID: 39408730
PMC: 11476574.
DOI: 10.3390/ijms251910401.
Extracellular Vesicles: Diagnostic and Therapeutic Applications in Cancer.
Di Bella M, Taverna S
Biology (Basel). 2024; 13(9).
PMID: 39336143
PMC: 11446462.
DOI: 10.3390/biology13090716.
Revolutionizing cancer therapy: nanoformulation of miRNA-34 - enhancing delivery and efficacy for various cancer immunotherapies: a review.
Fawzy M, Hassan H, Sedky N, Nafie M, Youness R, Fahmy S
Nanoscale Adv. 2024; .
PMID: 39309515
PMC: 11414826.
DOI: 10.1039/d4na00488d.
Apoptotic Vesicles: Therapeutic Mechanisms and Critical Issues.
Ou Q, Huang W, Wang B, Niu L, Li Z, Mao X
J Dent Res. 2024; 103(11):1057-1065.
PMID: 39272215
PMC: 11653339.
DOI: 10.1177/00220345241265676.
Tailoring of apoptotic bodies for diagnostic and therapeutic applications:advances, challenges, and prospects.
Miao X, Wu X, You W, He K, Chen C, Pathak J
J Transl Med. 2024; 22(1):810.
PMID: 39218900
PMC: 11367938.
DOI: 10.1186/s12967-024-05451-w.
Extracellular Vesicles as Drug Delivery System for Cancer Therapy.
Wang J, Yin B, Lian J, Wang X
Pharmaceutics. 2024; 16(8).
PMID: 39204374
PMC: 11359799.
DOI: 10.3390/pharmaceutics16081029.
Exosome-drug conjugates delivery: a promising strategy for ameliorating the pharmacokinetic profile of artesunate.
Wang D, Bai Y, Cheng G, Shen S, Xiao G, Ma D
Front Bioeng Biotechnol. 2024; 12:1437787.
PMID: 39188369
PMC: 11345266.
DOI: 10.3389/fbioe.2024.1437787.